Results 21 to 30 of about 21,171,014 (388)

A review of evidence about behavioural and psychological aspects of chronic joint pain among people with haemophilia [PDF]

open access: yes, 2014
Joint pain related to haemophilia affects large numbers of people and has a significant impact on their quality of life. This article reviews evidence about behavioural and psychological aspects of joint pain in haemophilia, and considers that evidence ...
Acharya   +75 more
core   +2 more sources

Adherence to prophylaxis in adolescents and young adults with severe haemophilia, A qualitative study with patients [PDF]

open access: yes, 2018
© 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.Abstract Introduction: Reported levels of adherence to prophylaxis among young people with haemophilia (YPH) vary widely and are predominately based on estimations ...
Khair K.   +6 more
core   +3 more sources

Utilization evaluation of factor concentration and frequencyof bleeds among patients with haemophilia "A" and haemophilia "B" in northwest Iran [PDF]

open access: yesJournal of Analytical Research in Clinical Medicine, 2013
Background Haemophilia A and B are X-linked bleeding disorders which result in decreased blood levels of coagulants. According to some studies, Hemophilia Severity Score (HSS) is higher in severe Haemophilia A(HA) than in severe Haemophilia B(HB ...
Roya Dolatkhah   +5 more
doaj   +1 more source

Haemophilia A and haemophilia B: molecular insights [PDF]

open access: yesMolecular Pathology, 2002
This review focuses on selected areas that should interest both the scientist and the clinician alike: polymorphisms within the factor VIII and factor IX genes, their linkage, and their ethnic variation; a general assessment of mutations within both genes and a detailed inspection of the molecular pathology of certain mutations to illustrate the ...
openaire   +4 more sources

Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study

open access: yesHaemophilia, 2020
The efficacy and safety of recombinant factor VIII Fc fusion protein (rFVIIIFc) as an extended half‐life treatment for severe haemophilia A were demonstrated in the Phase 3 A‐LONG and Kids A‐LONG studies. Eligible subjects who completed A‐LONG and Kids A‐
B. Nolan   +14 more
semanticscholar   +1 more source

Processes and experiences of satellite haemophilia clinic set-ups in Uganda – a short report

open access: yesThe Journal of Haemophilia Practice, 2022
Haemophilia knowledge and care are largely missing in much of sub-Saharan Africa and there is a need for concerted efforts to ensure access to care services by affected persons. Haemophilia Foundation Uganda, supported by the global haemophilia community
Kasirye Philip   +3 more
doaj   +1 more source

The history and evolution of the clinical effectiveness of haemophilia type a treatment: a systematic review. [PDF]

open access: yes, 2012
First evidence of cases of haemophilia dates from ancient Egypt, but it was when Queen Victoria from England in the 19th century transmitted this illness to her descendants, when it became known as the "royal disease".
A Aleem   +48 more
core   +2 more sources

Haemophilia A: pharmacoeconomic review of prophylaxis treatment versus on-demand [PDF]

open access: yes, 2015
Objectives. Haemophilia A is a congenital disorder of coagulation that mainly affects males and causes a considerable use of resources, especially when hemophilic patients are treated with prophylaxis.
BOCCIA, Antonio   +4 more
core   +2 more sources

Management of people with haemophilia A undergoing surgery while receiving emicizumab prophylaxis: Real‐world experience from a large comprehensive treatment centre in the US

open access: yesHaemophilia, 2020
Surgery is frequently required in persons with haemophilia A (PwHA). Emicizumab, a bispecific, humanized monoclonal antibody, bridges activated factor (F) IX and FX.
M. Lewandowska   +6 more
semanticscholar   +1 more source

Limited factor VIIa surface localization requirement of the factor VIIa–induced overall thrombin generation in platelet‐rich hemophilia A plasma

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2019
Background Thrombin generation assay (TGA) and thrombelastography (TEG) are increasingly employed, global, in vitro methods for assessment of the procoagulant potential of plasma/blood and possibly ideally suited tools to monitor, for example, therapy ...
Egon Persson, Mette Winther
doaj   +1 more source

Home - About - Disclaimer - Privacy